Tag: biotech penny stocks
Biotech Penny Stocks Investing Guide
So, investing in penny stocks is difficult and nuanced. But, when we look at biotech penny stocks, we see that there are some key differences. For one, biotech penny stocks happen to be much more volatile than non-biotech penny stocks. This has to do with the nature of the industry and the amount of news […]
7 Biotech Penny Stocks With Huge Catalysts Coming In 2022
Risk takers should start prepping Plowing through the most populated regions of the world like a hurricane, the novel coronavirus was and still is an unrelenting force. According to the time of writing data from Worldometers.info, 4.86 million people succumbed to the SARS-CoV-2 virus worldwide. But like any calamity, this too shall pass. Regular folks […]
4 Top Biotech Stocks To Be Purchased On The Cheap
Biotech stocks took a tumble last week, but for the long-term investor these valuations are a gift. Snap up shares of these four promising stocks for a discount today and take advantage of these too-low prices. Last week was brutal for biotech investors. The main indices dropped more than six percent just in Tuesday’s and […]
4 Takeover Targets In The Market’s Hottest Sector
There has been a fast and furious resurgence in M&A in this sector with tens of billions of dollars of deals going down in just the last couple of months. With expectations that dealmaking will continue to increase, consider these four stocks as solid investments with the chance for huge returns if they are purchased […]
4 Must-Own Biotech Stocks As The Sector Comes Charging Back
Up 20% over the last three months, the biotech sector has come roaring back with a vengeance. Given the positive outlook for this sector, Bret Jensen shares his four “must-own” picks through year-end. After three quarters of significantly underperforming the overall market, the biotech sector has roared back in a big way so far in […]
Buy These 3 Stocks Insiders Love
When insiders step up and put millions of their own dollars on the line to purchase company stock, investors should take notice. Don’t wait to only then see these stocks on CNBC rocketing up double-digits, buy shares today. After over two decades of successfully investing in the volatile and lucrative small biotech space, I have […]
The Next 3 Major Biotech Takeover Targets
After record years for deal volume in both 2014 and 2015 in the biotech and pharma industries, M&A transactions have posted a significant decline in the volume of deals so far in 2016 across these industries. As of late August, transactions based on dollar volume were down almost 65% from the same period in 2015. […]
3 Biotech Stocks That Can Double Before The End Of 2016
And, that is no exaggeration, these three biotech stocks all have near-term catalysts right around the corner that will send their currently undervalued share prices soaring when positive. Grab shares today because the catalysts we’re targeting for growth start happening in September. One of the keys to investing in the small cap portion of the […]
4 Undervalued Growth Stocks Deserving Your Interest
Pick up your pen and paper and write down the names of these four stocks that right now trade for valuations too low for their potential growth. With most stocks tading for premiums right now, finding four growth stocks with attractive valuations to add to your portfolio is worth your attention. I have followed and […]
4 Stocks To Buy With The Spread Of Zika
The Zika virus has been all over the news recently. It obviously is a backdrop for the Summer Olympics given the host country Brazil is the epicenter for this recent outbreak. The President and Congress continue to duel it out on assigning funding to tackle the virus from spreading further than it already has in […]
4 Likely Biotech Takeover Targets To Buy
After biotech stock Relypsa was bought out last week for a 60% premium, the odds of M&A heating up in this sector increased dramatically. Bret Jensen shares four more likely takeover targets that should be on your watchlist. It was a good week for the Biotech Gems portfolio. Progenics Pharmaceuticals (NASDAQ: PGNX) leapt 25% in […]
